WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New DDDs

List of new DDDs decided at the latest meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the DDDs should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the new DDDs will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list.

 

ATC codeATC level name (INN/generic name)DDDUnitAdm.routeDeadline for objection to temporary DDDs Implementation in ATC/DDD index if no objection is received
A04AA05palonosetron0.5mgO01.02.20142015
A06AX04linaclotide0.29mgO01.02.20142015
A10BX10lixisenatide20mcgP01.02.20142015
B02BD11catridecacog2.5TUP01.02.20142015
C01EB21regadenoson0.4mgP01.02.20142015
G04BE10avanafil0.1gO01.02.20142015
J01CF06 nafcillin3gP01.02.20142015
J05AX12dolutegravir50mgO01.02.20142015
J05AX13umifenovir0.8gO01.02.20142015
L02BB04enzalutamide0.16gO01.02.20142015
L03AA14lipegfilgrastim0.3mgP01.02.20142015
L03AB14cepeginterferon alfa-2b17mcgP01.02.20142015
L04AX06pomalidomide3mgO01.02.20142015
M04AX02pegloticase0.57mgP01.02.20142015
N05AE05lurasidone60mgO01.02.20142015
N07BB05nalmefene 18mgO01.02.20142015
N07XX09dimethyl fumarate0.48gO01.02.20142015
R06AX29bilastine20mgO01.02.20142015

Last updated: 2013-12-03